November 8, 2011
Pfizer Japan announced on November 7 that the company has filed an application with the Ministry of Health, Labor and Welfare (MHLW; Korosho ) for an additional indication for its anticancer drug Sutent (sunitinib malate) for the treatment of unresectable,...read more